Picture of Delta-Fly Pharma logo

4598 — Delta-Fly Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: Delta-Fly Pharma - 6-MTH parent results

Nov 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Sep 30, 2024        Sep 30, 2023       Mar 31, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating     loss 916 mln        loss 593 mln        loss 1.82    
  Recurring     loss 915 mln        loss 599 mln        loss 1.83    
  Net           loss 917 mln        loss 600 mln        loss 1.83    
  EPS          loss 111.44 yen     loss 91.92 yen    loss 222.34 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T

Recent news on Delta-Fly Pharma

See all news